Skip to main content

Sotera Health Co

For the period ended Dec 31, 2023. Filed Feb 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

SHC$16.44+2.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Schedule II – Valuation and Qualifying Accounts

DescriptionBalance atBeginning ofPeriodCharges(credits) tocosts andexpense(1)Deductions(2)TranslationAdjustments(3)Balance at Endof Period
Deducted from asset accounts:
Allowance for uncollectible accounts receivable$1,871$4,313$(1,502)$7$4,689
Deferred tax asset valuation allowance105,60019,682—153125,435
Deducted from asset accounts:
Allowance for uncollectible accounts receivable$1,287$1,009$(419)$(6)$1,871
Deferred tax asset valuation allowance52,08053,945—(425)105,600
Deducted from asset accounts:
Allowance for uncollectible accounts receivable$708$1,132$(408)$(145)$1,287
Deferred tax asset valuation allowance43,7658,455—(140)52,080

(1)For the year ended December 31, 2023, certain charges were recorded as a reduction to revenue

(2)Uncollectible accounts written off, net of recoveries

(3)Change in foreign currency exchange rates

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.